BioCentury
ARTICLE | Top Story

Pharmacia's parecoxib non-approvable

July 13, 2001 7:00 AM UTC

PHA announced after market close that it received a non-approvable letter from the FDA for parecoxib, an injectable specific cyclooxygenase-2 (COX-2) inhibitor to treat moderate to severe pain. PHA sa...